Abbott Laboratories (NYSE:ABT) currently has a daily average trading volume of 5.73M but it saw 11990626 shares traded in last market. With a market cap of 183.76B USD, the company’s current market price of $105.90 came falling about -3.03 while comparing to the previous closing price of $109.21. In past 52 weeks, the stock remained buoying in the range of price level as high as $121.64 and as low as $89.67.
Taking a look at 20-day trading activity of Abbott Laboratories (ABT) gives us an average price of $110.88, while its current price level is -12.94% below from 52-week high level whereas it is 18.09% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $114.44 while that of 200 days or SMA-200 reads an average of $106.70. A closer look into the stock’s movement over the week reveals that its volatility is standing at 2.31% during that period while stretching the period over a month that decreases to 1.72%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 30.59 which implies that the stock is in neutral territory.
Morgan Stanley downgraded its recommendation for the stock as a “Equal-Weight” from “Overweight” on May 30, 2023 while assigning a price target of $112. Wolfe Research issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $107 and $103.
Over the week, ABT’s stock price is moving -4.74% down while it is -5.82% when we observe its performance for the past one month. Year-to-date it is -3.79% down and over the past year, the stock is showing an upside performance of 1.32%.
Currently, Abbott Laboratories’s total number of outstanding shares is 1.73B. Company’s return on investment (ROI) stands at 10.56% and return on equity (ROE) at 15.15%. It has a price to earnings ratio (P/E ratio) of 32.96 while having a 20.60 of forward P/E ratio. Stock’s beta reads 0.74. Stock has a price to book (P/B) ratio of 4.76 while price to sale or P/S ratio amounts to 4.56. Its return on asset (ROA) is 7.72% on average.
